Anti-An. darlingi IgG | Anti-CTG IgG | Anti-STE IgG | Anti-gSG6-P1 IgG | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Estimated coefficient | SE | 95% CI | Estimated coefficient | SE | 95% CI | Estimated coefficient | SE | 95% CI | Estimated coefficient | SE | 95% CI | |
Fixed effects | ||||||||||||
Intercept | 0.428 | 0.046 | 0.191 | 0.036 | 0.313 | 0.047 | 0.128 | 0.024 | ||||
Infectious status | ||||||||||||
Uninfected | 1 | 1 | 1 | 1 | ||||||||
Infected | − 0.022 | 0.037 | − 0.096 to 0.051 | 0.007 | 0.029 | − 0.051 to 0.064 | − 0.005 | 0.038 | − 0.080 to 0.069 | 0.021 | 0.020 | − 0.018 to 0.060 |
Age | − 0.003 | 0.001 | − 0.004 to − 0.001 | − 0.002 | 0.001 | − 0.003 to − 0.001 | − 0.003 | 0.001 | − 0.005 to − 0.001 | 0.001 | 0.000 | 0.000 to 0.002 |
Residence time | ||||||||||||
< 5 years | 1 | 1 | 1 | 1 | ||||||||
≥ 5 years | − 0.031 | 0.030 | − 0.090 to 0.029 | − 0.007 | 0.024 | − 0.054 to 0.040 | − 0.032 | 0.031 | − 0.093 to 0.029 | − 0.035 | 0.016 | − 0.070 to − 0.003 |
Pf-MSP | 0.066 | 0.054 | − 0.041 to 0.172 | 0.106 | 0.043 | 0.022 to 0.189 | 0.092 | 0.055 | − 0.017 to 0.200 | 0.070 | 0.029 | 0.013 to 0.126 |
Village level | 6.51E−22 | 1.56E−20 | 4.31E−27 | 9.71E−26 | 7.13E−27 | 1.48E−25 | 2.46E−05 | 1.96E−04 |